Profit before tax in Q3 FY25 stood at Rs 27.92 crore, up 40.23% from Rs 19.91 crore posted in same quarter last year.
Total expenses rose 20.53% YoY to Rs 141.85 crore during the quarter. Cost of materials and services consumed was at Rs 44.79 crore (up 17.84% YoY) while employee benefits expenses stood at Rs 35.09 crore (up 33.12%) during the period under review.
The company's revenue from Diagnostic Testing Services was at Rs 151.87 crore (up 24.05% YoY), while revenue from Imaging Services stood at Rs 13.43 crore (up 13.24% YoY) in Q3 FY25.
EBITDA improved 32% YoY to Rs 41.6 crore in the December 2024 quarter from Rs 31.6 crore reported in the corresponding period the previous year. EBITDA margin increased to 25% in Q3 FY25 compared to 23% reported in the corresponding quarter last fiscal.
Thyrocare Technologies is engaged in the healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories, and hospitals in India.